A phase III single-arm study to evaluate the efficacy and safety of paclitaxel-hyaluronic acid conjugate administered intravesically to patients with BCG-unresponsive carcinoma in situ of the bladder with or without Ta-T1 papillary disease (Orion-BC study). Article

Full Text via DOI: 10.1200/JCO.2025.43.5_suppl.TPS885 Web of Science: 001454666200027

Cited authors

  • Kates M, Bardot S, Guerrero-Ramos F, Guy L, Hurle R, Marcq G, Moschini M, Pignot G, Porreca A, Soria F, Macchi A, Robert G Sr, Walczak R

Authors

Publication date

  • 2025

Published in

International Standard Serial Number (ISSN)

  • 0732-183X

Number of pages

  • 1

Start page

  • TPS885

End page

  • TPS885

Volume

  • 43

Issue

  • 5_SUPPL